Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has today launched its transformative Conjugated Polymer Nanoparticle (CPN™) products with life science distributors 2BScientific. Current bioimaging products have weak fluorescence and low sensitivities, which often fade prematurely. Stream Bio’s non-toxic molecular bioimaging probes, known as CPNs™, are set […]
Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, has today launched its transformative Conjugated Polymer Nanoparticle (CPN™) products with life science distributors 2BScientific. Current bioimaging products have weak fluorescence and low sensitivities, which often fade prematurely. Stream Bio’s non-toxic molecular bioimaging probes, known as CPNs™, are set […]
New license agreements for CRISPR technology from Broad Institute and ERS Genomics extend industry-leading genome editing capabilities CARLSBAD, Calif. — Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio. Under the terms of […]
AMSBIO announce the launch of a new range of circulating tumor DNA (ctDNA) Reference Standards for cancer disease management research. A critical goal in cancer disease management is early detection. When detected early, cancer progression can be arrested using techniques such as targeted therapy, chemotherapy and surgery thereby increasing the chances of survival and a […]
Integrating CNV analysis into a NextGen sequencing clinical analytics platform Bozeman, MT — Golden Helix, Inc., an industry-leading genomic analytics company that specializes in clinical Next-Gen Sequencing analysis software, has announced today that the National Institutes of Health awarded them a Phase 2 SBIR Grant 2R44 GM125432-02 “Integrating CNV analysis into a NextGen sequencing clinical analytics […]
Cambridge, United Kingdom – Congenica, the global diagnostic decision support platform provider, today announced it has entered into an agreement with a new strategic partner Digital China Health Technologies Cooperation Limited (DCHealth), further extending Congenica’s commitment to the Chinese market. The new partnership will see Congenica develop a version of its Sapientia™ platform designed to enable clinicians and […]
QIAGEN to launch two Sample to Insight systems in Europe and other markets, NeuMoDx to commercialize in the U.S. / Initial assay menu for infectious diseases and LDTs Hilden, Germany, and Ann Arbor, Michigan – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced a strategic partnership to commercialize two new […]
BEIJING — Genecast Biotechnology Co. Ltd. (Genecast) announced it has just reached strategic partnership agreement with the global leader in DNA sequencing and array-based technologies, Illumina. Genecast will seek to advance cancer diagnosis using Illumina’s next-generation sequencing (NGS) technology. Both companies are at the forefront of their fields – Illumina in gene sequencing and Genecast in […]
-Streamlining the Gene Testing Processes to Standardize the Testing- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu), Toppan Printing Co., Ltd. (HQ: Tokyo, Japan; President & Representative Director: Shingo Kaneko) and RIKEN GENESIS Co., Ltd. (HQ: Tokyo, Japan; President & CEO; Naoto Kondo) have jointly developed the LW-100 Gene Measurement Analyzer (research use […]
Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announces AstraZeneca has adopted its Edit-R™ crRNA libraries as part of AstraZeneca’s drive to establish a functional genomics discovery platform. AstraZeneca also joins the Genomics Discovery Initiative (GDI), a collaborative functional genomics screening […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
